Targeted RNA‐seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes-Reference-Cited by-同舟云学术

Targeted RNA‐seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes

Published:2019-02-07 Issue:2 Volume:145 Page:401-414
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Brandão Rita D.¹^ORCID,Mensaert Klaas²,López‐Perolio Irene³,Tserpelis Demis¹,Xenakis Markos¹⁴,Lattimore Vanessa⁵^ORCID,Walker Logan C.⁵^ORCID,Kvist Anders⁶^ORCID,Vega Ana⁷^ORCID,Gutiérrez‐Enríquez Sara⁸^ORCID,Díez Orland⁸⁹^ORCID,Hoya Miguel³^ORCID,Spurdle Amanda B.¹⁰^ORCID,De Meyer Tim²¹¹^ORCID,Blok Marinus J.¹^ORCID,

Affiliation:

1. Department of Clinical GeneticsMaastricht University Medical Centre+, GROW‐ School for Oncology and Developmental Biology Maastricht The Netherlands

2. Department of Data Analysis and Mathematical Modelling and Bioinformatics Institute Ghent N2NGhent University Ghent Belgium

3. Molecular Oncology Laboratory CIBERONCHospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) Madrid Spain

4. Department of Data Science and Knowledge EngineeringMaastricht University Maastricht The Netherlands

5. Department of Pathology and Biomedical ScienceUniversity of Otago Christchurch New Zealand

6. Division of Oncology and Pathology, Department of Clinical SciencesLund University Lund Sweden

7. Fundación Pública Galega de Medicina Xenómica‐Servicio Galgo de SaúdeGrupo de Medicina Xenómica‐USC, CIBERER, IDIS Santiago de Compostela Spain

8. Oncogenetics GroupVall d'Hebron Institute of Oncology (VHIO) Barcelona Spain

9. Area of Clinical and Molecular GeneticsUniversity Hospital of Vall d'Hebron Barcelona Spain

10. Department of Genetics and Computational BiologyQIMR Berghofer Medical Research Institute Brisbane QLD Australia

11. CRIG (Cancer Research Institute Ghent)Ghent University Ghent Belgium

Funder

Fundación Mutua Madrileña

Horizon 2020 Framework Programme

National Health and Medical Research Council

National Breast Cancer Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32114

Reference50 articles.

1. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

2. RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families

3. Germline mutations in RAD51D confer susceptibility to ovarian cancer

4. Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population

5. Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing;World Journal of Oncology;2024-08

2. RNA Panel Sequencing Is an Effective Tool to Help Classify Splice Variants for Clinical Oncogenetic Diagnosis;Human Mutation;2024-04-02

3. Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations;Clinica Chimica Acta;2024-01

4. Parallel DNA/RNA NGS Using an Identical Target Enrichment Panel in the Analysis of Hereditary Cancer Predisposition;Folia Biologica;2024

5. Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup;The American Journal of Human Genetics;2023-07